Clinical Trials Logo

Clinical Trial Summary

This study aims to recognize the effects of subclinical hypothyroidism on bone mineral density, Not many studies were done on this subject


Clinical Trial Description

A lot of different factors are necessary for the harmonious development as well as normal functioning of skeleton: genetic conditions, hormonal and metabolic homeostasis, balanced diet, mechanical load. Any disturbances of those agents can lead to serious and dangerous consequences like length reduction, deformations, and fractures. Their results depend, between other, on one's age, type of disorder and its duration.

- There are a lot of endocrinological reasons of secondary osteoporosis (for example: Cushing's syndrome, hyperparathyroidism, hypogonadism, acromegaly, diabetes mellitus, hypothyroidism etc..

Any changes of normal thyroid function and Thyroid stimulating hormones (TSH) directly affects the remodeling of bone through TSH receptor found on osteoblast and osteoclast precursor cells.

TSH has a positive correlation with body mass index (BMI) in women; though, this correlation is insignificant in male. Women having subclinical hypothyroidism have reduced femoral neck bone mineral density (BMD). The variations in thyroid function are primary, while changes in body weight and bones are secondary. The physiological variation of thyroid hormones is associated with changes in BMD and non vertebral fracture risk in healthy postmenopausal women.

The definition of osteoporosis by the world health organization (WHO) is densitometric and non-clinical and is based on the measurement of bone mass and dexa method in the spine or hip. There is still controversy about the relation between thyroid hormones, osteoporosis and BMD in female hypothyroid patients. This study aims to fill the gaps in our understanding of impact of subclinical hypothyroid disorder on bone densitometry. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04270110
Study type Observational
Source Assiut University
Contact Kareem Mohammed, Master
Phone 01032781933
Email kareemmohammed81993@gmail.com
Status Recruiting
Phase
Start date January 1, 2020
Completion date December 31, 2021

See also
  Status Clinical Trial Phase
Completed NCT03569787 - Hyperprolactinaemia Management in Reproductive Services at University Hospital of Coventry and Warwickshire
Withdrawn NCT02186405 - Effects of Levothyroxine Treatment on Hemodynamic and Renal Functions in Subclinical Hypothyroidism Phase 4
Recruiting NCT03606824 - Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study) N/A
Recruiting NCT05638269 - A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
Not yet recruiting NCT04178928 - Can Levothyroxine Treatment Reduce the Development of Cardio-metabolic Disorder in Subclinical Hypothyroidism? Phase 1/Phase 2
Recruiting NCT05842096 - Subclinical Hypothyroidism and Chronic Inflammation in PCOS N/A
Recruiting NCT05803967 - Baduanjin Exercising Effects on Sub-clinical Hypothyroidism and Cognitive Problems N/A
Recruiting NCT06409520 - Impact Of Subclinical Hypothyroidism On Short-Term Outcomes In Patients With Acute Coronary Syndrome In Sohag University Hospitals